In line with our previous studies (Sun et al., 2019), PD-1 blocking antibody showed some efficacies in the mouse model of lung cancer, as evidenced by the significant decrease in tumor burden and tumor number (Figure 5C). This evidence concerns the gene PDCD1 and neoplasm.